WO2013053034A3 - Thiazacridines used in anti-cancer therapy - Google Patents
Thiazacridines used in anti-cancer therapy Download PDFInfo
- Publication number
- WO2013053034A3 WO2013053034A3 PCT/BR2012/000421 BR2012000421W WO2013053034A3 WO 2013053034 A3 WO2013053034 A3 WO 2013053034A3 BR 2012000421 W BR2012000421 W BR 2012000421W WO 2013053034 A3 WO2013053034 A3 WO 2013053034A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- thiazacridines
- cancer therapy
- denominated
- thiazolidine
- acridinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
The present invention relates to 3-acridinyl-methyl-thiazolidine-2,4-dione-derived compounds, also denominated thiazacridines, and to the related processes for chemically synthesizing same, and also to the therapeutic use thereof for treating cancer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI1106333 | 2011-10-10 | ||
BRPI1106333-5 | 2011-10-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013053034A2 WO2013053034A2 (en) | 2013-04-18 |
WO2013053034A3 true WO2013053034A3 (en) | 2013-06-27 |
Family
ID=48082600
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/BR2012/000421 WO2013053034A2 (en) | 2011-10-10 | 2012-10-24 | Thiazacridines used in anti-cancer therapy |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2013053034A2 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004024058A2 (en) * | 2002-09-10 | 2004-03-25 | Conselho Nacional De Desenvolvimento Científico E Tecnológico - Cnpq | Molecules with antitumor activity and chemical synthesis |
WO2007109871A2 (en) * | 2006-03-24 | 2007-10-04 | Universidade Federal De Pernambuco - Ufpe | Acridine derivatives with antitumoral activity |
-
2012
- 2012-10-24 WO PCT/BR2012/000421 patent/WO2013053034A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004024058A2 (en) * | 2002-09-10 | 2004-03-25 | Conselho Nacional De Desenvolvimento Científico E Tecnológico - Cnpq | Molecules with antitumor activity and chemical synthesis |
WO2007109871A2 (en) * | 2006-03-24 | 2007-10-04 | Universidade Federal De Pernambuco - Ufpe | Acridine derivatives with antitumoral activity |
Non-Patent Citations (2)
Title |
---|
R.H. MOURAO ET AL.: "Synthesis and Biological Activity of Novel Acridinylidene and Benzylidene thiazolidinediones", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 40, 2005, pages 1129 - 1133, XP005113105 * |
WILLIAM A. DENNY: "Acridine Derivatives as Chemotherapeutic Agents", CURRENT MEDICINAL CHEMISTRY, vol. 9, 2002, pages 1655 - 1665, XP009073854 * |
Also Published As
Publication number | Publication date |
---|---|
WO2013053034A2 (en) | 2013-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276434A (en) | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer | |
IL279330A (en) | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer | |
HK1219486A1 (en) | Therapy involving antibodies against claudin 18.2 for treatment of cancer 18.2 | |
WO2013177187A3 (en) | Synergistic tumor treatment with extended-pk il-2 and therapeutic agents | |
WO2013114367A8 (en) | C10rf32 antibodies, and uses thereof for treatment of cancer | |
WO2012062925A3 (en) | Compounds and methods for treating pain | |
MX2014011134A (en) | Carbamate compounds and of making and using same. | |
PH12014502406A1 (en) | Anti-il-23p19 antibodies | |
PH12015501088A1 (en) | Dimeric compounds | |
WO2012103810A1 (en) | Certain chemical entities, compositions, and methods | |
RS56187B1 (en) | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer | |
WO2007140804A8 (en) | A process for the preparation of an oxaliplatin | |
WO2012158776A3 (en) | Combination therapy for treatment of cancer | |
WO2013053034A3 (en) | Thiazacridines used in anti-cancer therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12839760 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12839760 Country of ref document: EP Kind code of ref document: A2 |